Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Whipple Operation
Interventions
DRUG

Dachengqi decoction

experimental Participants received Dachengqi decoction (50 ml BID) via pump infusion at 10 ml/h starting 12 hours postoperatively, continuing through postoperative days 1-3.

PROCEDURE

modified gastrointestinal dual-lumen feeding tube

experimental and control group participants underwent intraoperative placement of modified gastrointestinal dual-lumen feeding tubes with distal ends positioned 15-20 cm distal to the gastrojejunostomy anastomosis (all devices were uniformly procured by China-Japan Friendship Hospital).

DRUG

Normal Saline (0.9% NaCl)

control group participants were administered glucose and sodium chloride injection (50 ml BID) via pump infusion at 10 ml/h starting 12 hours postoperatively, continuing through postoperative days 1-3.

Trial Locations (1)

100029

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

China-Japan Friendship Hospital

OTHER

NCT06948474 - Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery | Biotech Hunter | Biotech Hunter